What is Astrana Health's shares issued for vesting of restricted stock awards?

Astrana Health (ASTH) reported shares issued for vesting of restricted stock awards of -$1.17M in Q1 2026.

Astrana Health ASTH Shares Issued For Vesting Of Restricted Stock Awards

Revenue$965.1M+55.6%

Gross profit$105.7M+48.2%

Operating income$28.5M+38.6%

Net income$14.4M+116%

EPS (diluted)$0.29+107%

Cash & equivalents$478.4M+85.0%

Total debt$1.1B+136%

Total equity$800.3M+7.4%

Total assets$2.4B+77.2%

Operating cash flow$68.1M+309%

CapEx$4.0M+30.3%

Free cash flow$64.1M+372%

Market cap$2.1B-3.0%

Gross margin10.7%-1.3pp

Operating margin2.5%-1.1pp

Net margin0.9%—

FCF margin4.6%—

Return on equity3.9%—

Debt / equity1.3×+0.7×

Current ratio1.3×-0.4×

Reported directly by Astrana Health in its filing.

Tagged under the XBRL concept asth:SharesIssuedForVestingOfRestrictedStockAwards.

The official record: Astrana Health’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

What is Astrana Health's shares issued for vesting of restricted stock awards?: Astrana Health (ASTH) reported shares issued for vesting of restricted stock awards of -$1.17M in Q1 2026.
How has Astrana Health's shares issued for vesting of restricted stock awards changed year-over-year?: Astrana Health's shares issued for vesting of restricted stock awards increased by 71.1% year-over-year, from -$4.05M to -$1.17M.